News FDA approves new Alzheimer’s drug, Aduhelm, the first in nearly two decades June 7, 2021 Ken Alltucker, USA TODAY Comments Off on FDA approves new Alzheimer’s drug, Aduhelm, the first in nearly two decades The FDA's landmark authorization of Biogen's Aduhelm requires the drug company to conduct a post-approval study to monitor its effectiveness.